A microRNA driver of B-cell leukaemia

Risk adapted therapy for acute myeloid leukaemia

Clinical characteristics and prognostic factors of plasmablastic lymphoma patients

Killer antibodies against AML

Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia

Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence

Stopping tyrosine kinase inhibitors in CML

Sequencing analysis with circulating DNA

Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC

Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma

Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer.

Daratumumab slows progression in refractory multiple myeloma